“…In addition, there are still no effective and curative pharmacologic treatments for patients with cataracts [ 15 ]. Despite the potentially poor results of re-impaired visual acuity caused by the surgery complications, including phototoxic retinal damage during the surgery, postoperative posterior capsular opacification (PCO), capsular contraction syndrome (CCS), pseudophakic cystoid macular edema (PCME), increased intraocular pressure (IOP), and intraocular lens (IOL) dislocation [ 6 , 8 , 10 , 12 , 13 , 16 , 17 ], significant improvement of visual acuity and subjective symptoms in the majority of patients were also published in many studies [ 6 , 8 – 14 , 16 , 18 , 19 ].…”